The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors (Q34660274)

3 August 2017

title

The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors (English)

1 reference

3 August 2017

4

Zhiqiang Wu

1 reference

3 August 2017

Fan Jiang

1

1 reference

3 August 2017

Wei Chen

2

1 reference

3 August 2017

Kejia Yi

3

1 reference

3 August 2017

Yiling Si

5

1 reference

3 August 2017

Weidong Han

6

1 reference

3 August 2017

Yali Zhao

7

1 reference

3 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20832370

10 July 2024

publication date

15 September 2010

1 reference

full work available at URL

3 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S152166161000687X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

https://api.elsevier.com/content/article/PII:S152166161000687X?httpAccept=text/plain

10 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

10 July 2024

1 reference

3 August 2017

volume

137

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

347-356

1 reference

Integrase inhibitors to treat HIV/AIDS.

3 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

The hunt for HIV-1 integrase inhibitors

10 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial

10 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

10 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Raltegravir: a review of its use in the management of HIV infection in treatment-experienced patients

10 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens

10 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

10 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Antiviral effect of catechins in green tea on influenza virus

10 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Beneficial effects of green tea--a review.

10 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Green tea catechins as novel antitumor and antiangiogenic compounds

10 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy

10 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).

10 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent

10 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Observations on the inhibition of HIV-1 reverse transcriptase by catechins

10 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy

10 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding

10 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases

10 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

10 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking

10 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Discovery of a novel binding trench in HIV integrase.

10 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

10 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

10 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach

10 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

10 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.

10 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors

10 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Investigations on human immunodeficiency virus type 1 integrase/DNA binding interactions via molecular dynamics and electrostatics calculations.

10 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity

10 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Retroviral intasome assembly and inhibition of DNA strand transfer

10 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase

10 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals

10 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers

10 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail

10 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

Metabolism of green tea catechins: an overview

10 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

HIV-1 IN inhibitors: 2010 update and perspectives

10 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CLIM.2010.08.007

10 July 2024

Identifiers

1 reference

3 August 2017

1 reference